TreeWAS – Variant ID: rs2007029

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N73.6 Female pelvic peritoneal adhesions	0.265	0.735	0.000
N73 Other female pelvic inflammatory diseases	0.206	0.794	0.000
H34.8 Other retinal vascular occlusions	0.000	0.804	0.196
N73.9 Female pelvic inflammatory disease, unspecified	0.179	0.821	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.175	0.825	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.154	0.846	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.151	0.849	0.000
N73.4 Female chronic pelvic peritonitis	0.148	0.852	0.000
N73.3 Female acute pelvic peritonitis	0.148	0.852	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.148	0.852	0.000
N73.5 Female pelvic peritonitis, unspecified	0.142	0.858	0.000
H34 Retinal vascular occlusions	0.000	0.886	0.114
H34.1 Central retinal artery occlusion	0.000	0.895	0.105
H34.9 Retinal vascular occlusion, unspecified	0.000	0.913	0.087
H34.0 Transient retinal artery occlusion	0.000	0.918	0.082
H34.2 Other retinal artery occlusions	0.000	0.952	0.048
N70-N77 Inflammatory diseases of female pelvic organs	0.026	0.974	0.000
N71 Inflammatory disease of uterus, except cervix	0.020	0.980	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.020	0.980	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.019	0.981	0.000
N72 Inflammatory disease of cervix uteri	0.018	0.982	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.983	0.017
N71.9 Inflammatory disease of uterus, unspecified	0.016	0.984	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.015	0.985	0.000
N71.1 Chronic inflammatory disease of uterus	0.015	0.985	0.000
N70 Salpingitis and oophoritis	0.014	0.985	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.014	0.985	0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.014	0.985	0.000
N71.0 Acute inflammatory disease of uterus	0.014	0.986	0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.014	0.986	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.014	0.986	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.014	0.986	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.014	0.986	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.014	0.986	0.000
N74.0 Tuberculous infection of cervix uteri	0.014	0.986	0.000
N76 Other inflammation of vagina and vulva	0.013	0.987	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.011	0.989	0.000
C43.5 Malignant melanoma of trunk	0.000	0.989	0.011
N76.2 Acute vulvitis	0.011	0.989	0.000
N76.6 Ulceration of vulva	0.010	0.990	0.000
N70.0 Acute salpingitis and oophoritis	0.010	0.990	0.000
G30 Alzheimer's disease	0.000	0.990	0.010
N76.5 Ulceration of vagina	0.010	0.990	0.000
N76.3 Subacute and chronic vulvitis	0.010	0.990	0.000
N75 Diseases of Bartholin's gland	0.010	0.990	0.000
N76.4 Abscess of vulva	0.009	0.991	0.000
G30.8 Other Alzheimer's disease	0.000	0.991	0.009
N76.1 Subacute and chronic vaginitis	0.008	0.991	0.000
M54.22 Cervicalgia (Cervical region)	0.008	0.992	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.008	0.992	0.000
M19.94 Arthrosis, unspecified (Hand)	0.008	0.992	0.000
G30.1 Alzheimer's disease with late onset	0.000	0.993	0.007
N75.9 Disease of Bartholin's gland, unspecified	0.007	0.993	0.000
I24.8 Other forms of acute ischaemic heart disease	0.007	0.993	0.000
N75.8 Other diseases of Bartholin's gland	0.007	0.993	0.000
N76.0 Acute vaginitis	0.007	0.993	0.000
G30.0 Alzheimer's disease with early onset	0.000	0.993	0.007
M81.9 Osteoporosis, unspecified	0.006	0.994	0.000
H30-H36 Disorders of choroid and retina	0.000	0.994	0.006
N76.8 Other specified inflammation of vagina and vulva	0.005	0.994	0.000
M81.97 Osteoporosis, unspecified (Ankle and foot)	0.006	0.994	0.000
M81.98 Osteoporosis, unspecified (Other)	0.005	0.995	0.000
N70.1 Chronic salpingitis and oophoritis	0.005	0.995	0.000
T82.3 Mechanical complication of other vascular grafts	0.000	0.995	0.005
H30 Chorioretinal inflammation	0.000	0.995	0.005
I98.2 Oesophageal varices in diseases classified elsewhere	0.005	0.995	0.000
M81.93 Osteoporosis, unspecified (Forearm)	0.005	0.995	0.000
M81.92 Osteoporosis, unspecified (Upper arm)	0.005	0.995	0.000
M81.91 Osteoporosis, unspecified (Shoulder region)	0.005	0.995	0.000
M81.94 Osteoporosis, unspecified (Hand)	0.005	0.995	0.000
H30.2 Posterior cyclitis	0.000	0.995	0.004
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.995	0.004
G30-G32 Other degenerative diseases of the nervous system	0.000	0.995	0.005
R07.0 Pain in throat	0.005	0.995	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.004	0.995	0.000
N75.1 Abscess of Bartholin's gland	0.004	0.996	0.000
J31.2 Chronic pharyngitis	0.000	0.996	0.004
N75.0 Cyst of Bartholin's gland	0.004	0.996	0.000
M81.96 Osteoporosis, unspecified (Lower leg)	0.004	0.996	0.000
E21.3 Hyperparathyroidism, unspecified	0.004	0.996	0.000
J31.0 Chronic rhinitis	0.000	0.996	0.004
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.004	0.996	0.000
H30.8 Other chorioretinal inflammations	0.000	0.996	0.004
H30.1 Disseminated chorioretinal inflammation	0.000	0.996	0.004
H30.0 Focal chorioretinal inflammation	0.000	0.996	0.004
H31 Other disorders of choroid	0.000	0.996	0.004
J43.9 Emphysema, unspecified	0.004	0.996	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.996	0.004
M54.36 Sciatica (Lumbar region)	0.004	0.996	0.000
M54.2 Cervicalgia	0.004	0.996	0.000
M81 Osteoporosis without pathological fracture	0.004	0.996	0.000
S83.2 Tear of meniscus, current	0.000	0.996	0.004
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.004	0.996	0.000
G44.2 Tension-type headache	0.004	0.996	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.000	0.996	0.003
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.003
H30.9 Chorioretinal inflammation, unspecified	0.000	0.996	0.003
E21.0 Primary hyperparathyroidism	0.003	0.997	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.003	0.997	0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
I24 Other acute ischaemic heart diseases	0.003	0.997	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.000	0.997	0.003
M81.4 Drug-induced osteoporosis	0.003	0.997	0.000
N60.3 Fibrosclerosis of breast	0.000	0.997	0.003
I44.7 Left bundle-branch block, unspecified	0.003	0.997	0.000
G40 Epilepsy	0.003	0.997	0.000
D86.9 Sarcoidosis, unspecified	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.003	0.997	0.000
H31.9 Disorder of choroid, unspecified	0.000	0.997	0.003
H31.3 Choroidal haemorrhage and rupture	0.000	0.997	0.003
I98 Other disorders of circulatory system in diseases classified elsewhere	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
G44 Other headache syndromes	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M81.0 Postmenopausal osteoporosis	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.997	0.003
G31.2 Degeneration of nervous system due to alcohol	0.000	0.997	0.003
G31.0 Circumscribed brain atrophy	0.000	0.997	0.003
M81.49 Drug-induced osteoporosis (Site unspecified)	0.003	0.997	0.000
H31.4 Choroidal detachment	0.000	0.997	0.003
H31.2 Hereditary choroidal dystrophy	0.000	0.997	0.003
H53.9 Visual disturbance, unspecified	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
H31.8 Other specified disorders of choroid	0.000	0.997	0.003
E21.2 Other hyperparathyroidism	0.003	0.997	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.000	0.997	0.003
M54.28 Cervicalgia-Sacral/sacrococ	0.003	0.997	0.000
I24.1 Dressler's syndrome	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
M54.27 Cervicalgia-Lumbosacral	0.003	0.997	0.000
M54.26 Cervicalgia-Lumbar	0.003	0.997	0.000
M54.25 Cervicalgia-Thoracolumbar	0.003	0.997	0.000
M54.24 Cervicalgia-Thoracic	0.003	0.997	0.000
M54.20 Cervicalgia-Mult site	0.003	0.997	0.000
M81.6 Localised osteoporosis [Lequesne]	0.003	0.997	0.000
M81.5 Idiopathic osteoporosis	0.003	0.997	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.003	0.997	0.000
K74.5 Biliary cirrhosis, unspecified	0.003	0.997	0.000
M81.8 Other osteoporosis	0.003	0.997	0.000
M81.1 Postoophorectomy osteoporosis	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.003	0.997	0.000
E21.4 Other specified disorders of parathyroid gland	0.003	0.997	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.003	0.997	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.003	0.997	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.003	0.997	0.000
H36 Retinal disorders in diseases classified elsewhere	0.000	0.997	0.003
M81.09 Postmenopausal osteoporosis (Site unspecified)	0.003	0.997	0.000
H35.4 Peripheral retinal degeneration	0.000	0.997	0.003
D47.2 Monoclonal gammopathy	0.000	0.997	0.003
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.003	0.997	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.003	0.997	0.000
J31.1 Chronic nasopharyngitis	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
E21.5 Disorder of parathyroid gland, unspecified	0.003	0.997	0.000
G44.0 Cluster headache syndrome	0.003	0.997	0.000
H31.1 Choroidal degeneration	0.000	0.997	0.002
T40.4 Other synthetic narcotics	0.000	0.997	0.003
M54.29 Cervicalgia-Site unspe	0.003	0.997	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.000	0.997	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
I24.9 Acute ischaemic heart disease, unspecified	0.003	0.997	0.000
M81.48 Drug-induced osteoporosis (Other)	0.002	0.997	0.000
M81.47 Drug-induced osteoporosis (Ankle and foot)	0.002	0.997	0.000
M81.46 Drug-induced osteoporosis (Lower leg)	0.002	0.997	0.000
M81.45 Drug-induced osteoporosis (Pelvic region and thigh)	0.002	0.997	0.000
M81.44 Drug-induced osteoporosis (Hand)	0.002	0.997	0.000
M81.43 Drug-induced osteoporosis (Forearm)	0.002	0.997	0.000
M81.42 Drug-induced osteoporosis (Upper arm)	0.002	0.997	0.000
M81.41 Drug-induced osteoporosis (Shoulder region)	0.002	0.997	0.000
M81.3 Postsurgical malabsorption osteoporosis	0.002	0.997	0.000
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
G44.8 Other specified headache syndromes	0.003	0.997	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.002
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.997	0.003
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.002	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.002
D86 Sarcoidosis	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.003	0.997	0.000
M81.2 Osteoporosis of disuse	0.002	0.997	0.000
T40.6 Other and unspecified narcotics	0.000	0.997	0.002
M54.23 Cervicalgia (Cervicothoracic region)	0.002	0.997	0.000
G44.3 Chronic posttraumatic headache	0.002	0.997	0.000
T42.3 Barbiturates	0.000	0.997	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.002
G44.4 Drug-induced headache, not elsewhere classified	0.002	0.997	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.000	0.997	0.002
N80.2 Endometriosis of Fallopian tube	0.000	0.997	0.002
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.002	0.997	0.000
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
I98.0 Cardiovascular syphilis	0.002	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.002
T40.8 Lysergide [LSD]	0.000	0.997	0.002
T40.7 Cannabis (derivatives)	0.000	0.997	0.002
T40.0 Opium	0.000	0.997	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.002
M81.08 Postmenopausal osteoporosis (Other)	0.002	0.997	0.000
M81.07 Postmenopausal osteoporosis (Ankle and foot)	0.002	0.997	0.000
M81.06 Postmenopausal osteoporosis (Lower leg)	0.002	0.997	0.000
M81.05 Postmenopausal osteoporosis (Pelvic region and thigh)	0.002	0.997	0.000
M81.04 Postmenopausal osteoporosis (Hand)	0.002	0.997	0.000
M81.03 Postmenopausal osteoporosis (Forearm)	0.002	0.997	0.000
M81.02 Postmenopausal osteoporosis (Upper arm)	0.002	0.997	0.000
M81.01 Postmenopausal osteoporosis (Shoulder region)	0.002	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.002
T50.5 Appetite depressants	0.000	0.997	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.002
H35 Other retinal disorders	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.000	0.998	0.002
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
Q38.7 Pharyngeal pouch	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
M81.00 Postmenopausal osteoporosis (Multiple sites)	0.002	0.998	0.000
G44.1 Vascular headache, not elsewhere classified	0.002	0.998	0.000
H35.5 Hereditary retinal dystrophy	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
Z29.1 Prophylactic immunotherapy	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
I44.1 Atrioventricular block, second degree	0.002	0.998	0.000
J45.0 Predominantly allergic asthma	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
M81.59 Idiopathic osteoporosis (Site unspecified)	0.002	0.998	0.000
M81.58 Idiopathic osteoporosis (Other)	0.002	0.998	0.000
M81.57 Idiopathic osteoporosis (Ankle and foot)	0.002	0.998	0.000
M81.56 Idiopathic osteoporosis (Lower leg)	0.002	0.998	0.000
M81.55 Idiopathic osteoporosis (Pelvic region and thigh)	0.002	0.998	0.000
M81.54 Idiopathic osteoporosis (Hand)	0.002	0.998	0.000
M81.53 Idiopathic osteoporosis (Forearm)	0.002	0.998	0.000
M81.52 Idiopathic osteoporosis (Upper arm)	0.002	0.998	0.000
M81.51 Idiopathic osteoporosis (Shoulder region)	0.002	0.998	0.000
M81.50 Idiopathic osteoporosis (Multiple sites)	0.002	0.998	0.000
M81.69 Localized osteoporosis [Lequesne] (Site unspecified)	0.002	0.998	0.000
M81.68 Localized osteoporosis [Lequesne] (Other)	0.002	0.998	0.000
M81.67 Localized osteoporosis [Lequesne] (Ankle and foot)	0.002	0.998	0.000
M81.66 Localized osteoporosis [Lequesne] (Lower leg)	0.002	0.998	0.000
M81.65 Localized osteoporosis [Lequesne] (Pelvic region and thigh)	0.002	0.998	0.000
M81.64 Localized osteoporosis [Lequesne] (Hand)	0.002	0.998	0.000
M81.63 Localized osteoporosis [Lequesne] (Forearm)	0.002	0.998	0.000
M81.62 Localized osteoporosis [Lequesne] (Upper arm)	0.002	0.998	0.000
M81.61 Localized osteoporosis [Lequesne] (Shoulder region)	0.002	0.998	0.000
M81.60 Localized osteoporosis [Lequesne] (Multiple sites)	0.002	0.998	0.000
D86.3 Sarcoidosis of skin	0.002	0.998	0.000
H31.0 Chorioretinal scars	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
M81.88 Other osteoporosis (Other)	0.002	0.998	0.000
M81.87 Other osteoporosis (Ankle and foot)	0.002	0.998	0.000
M81.86 Other osteoporosis (Lower leg)	0.002	0.998	0.000
M81.85 Other osteoporosis (Pelvic region and thigh)	0.002	0.998	0.000
M81.84 Other osteoporosis (Hand)	0.002	0.998	0.000
M81.83 Other osteoporosis (Forearm)	0.002	0.998	0.000
M81.82 Other osteoporosis (Upper arm)	0.002	0.998	0.000
M81.81 Other osteoporosis (Shoulder region)	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
M81.19 Postoophorectomy osteoporosis (Site unspecified)	0.002	0.998	0.000
M81.18 Postoophorectomy osteoporosis (Other)	0.002	0.998	0.000
M81.17 Postoophorectomy osteoporosis (Ankle and foot)	0.002	0.998	0.000
M81.16 Postoophorectomy osteoporosis (Lower leg)	0.002	0.998	0.000
M81.15 Postoophorectomy osteoporosis (Pelvic region and thigh)	0.002	0.998	0.000
M81.14 Postoophorectomy osteoporosis (Hand)	0.002	0.998	0.000
M81.13 Postoophorectomy osteoporosis (Forearm)	0.002	0.998	0.000
M81.12 Postoophorectomy osteoporosis (Upper arm)	0.002	0.998	0.000
M81.11 Postoophorectomy osteoporosis (Shoulder region)	0.002	0.998	0.000
M81.89 Other osteoporosis (Site unspecified)	0.002	0.998	0.000
D86.0 Sarcoidosis of lung	0.002	0.998	0.000
G41.9 Status epilepticus, unspecified	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
H36.8 Other retinal disorders in diseases classified elsewhere	0.000	0.998	0.002
M81.80 Other osteoporosis (Multiple sites)	0.002	0.998	0.000
K31.7 Polyp of stomach and duodenum	0.000	0.998	0.002
G40-G47 Episodic and paroxysmal disorders	0.002	0.998	0.000
M81.10 Postoophorectomy osteoporosis (Multiple sites)	0.002	0.998	0.000
H35.9 Retinal disorder, unspecified	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
G46 Vascular syndromes of brain in cerebrovascular diseases	0.002	0.998	0.000
G41 Status epilepticus	0.002	0.998	0.000
M81.39 Postsurgical malabsorption osteoporosis (Site unspecified)	0.002	0.998	0.000
M81.38 Postsurgical malabsorption osteoporosis (Other)	0.002	0.998	0.000
M81.37 Postsurgical malabsorption osteoporosis (Ankle and foot)	0.002	0.998	0.000
M81.36 Postsurgical malabsorption osteoporosis (Lower leg)	0.002	0.998	0.000
M81.35 Postsurgical malabsorption osteoporosis (Pelvic region and thigh)	0.002	0.998	0.000
M81.34 Postsurgical malabsorption osteoporosis (Hand)	0.002	0.998	0.000
M81.33 Postsurgical malabsorption osteoporosis (Forearm)	0.002	0.998	0.000
M81.32 Postsurgical malabsorption osteoporosis (Upper arm)	0.002	0.998	0.000
M81.31 Postsurgical malabsorption osteoporosis (Shoulder region)	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
I44 Atrioventricular and left bundle-branch block	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
D86.1 Sarcoidosis of lymph nodes	0.002	0.998	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.002	0.998	0.000
G46.7 Other lacunar syndromes	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
M81.29 Osteoporosis of disuse (Site unspecified)	0.002	0.998	0.000
M81.28 Osteoporosis of disuse (Other)	0.002	0.998	0.000
M81.27 Osteoporosis of disuse (Ankle and foot)	0.002	0.998	0.000
M81.26 Osteoporosis of disuse (Lower leg)	0.002	0.998	0.000
M81.25 Osteoporosis of disuse (Pelvic region and thigh)	0.002	0.998	0.000
M81.24 Osteoporosis of disuse (Hand)	0.002	0.998	0.000
M81.23 Osteoporosis of disuse (Forearm)	0.002	0.998	0.000
M81.22 Osteoporosis of disuse (Upper arm)	0.002	0.998	0.000
M81.21 Osteoporosis of disuse (Shoulder region)	0.002	0.998	0.000
G40.8 Other epilepsy	0.002	0.998	0.000
G46.4 Cerebellar stroke syndrome	0.002	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.002	0.998	0.000
N39.8 Other specified disorders of urinary system	0.002	0.998	0.000
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
C71.9 Brain, unspecified	0.000	0.998	0.002
H35.2 Other proliferative retinopathy	0.001	0.998	0.001
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
G40.5 Special epileptic syndromes	0.002	0.998	0.000
H35.1 Retinopathy of prematurity	0.000	0.998	0.002
C49.0 Connective and soft tissue of head, face and neck	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
X49.9 Unspecified place	0.000	0.998	0.002
H35.6 Retinal haemorrhage	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
F43.2 Adjustment disorders	0.000	0.998	0.002
M19.1 Posttraumatic arthrosis of other joints	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.998	0.002
I44.6 Other and unspecified fascicular block	0.002	0.998	0.000
N05.9 Unspecified	0.000	0.998	0.002
T39.0 Salicylates	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
M81.30 Postsurgical malabsorption osteoporosis (Multiple sites)	0.002	0.998	0.000
G41.0 Grand mal status epilepticus	0.002	0.998	0.000
K70.9 Alcoholic liver disease, unspecified	0.002	0.998	0.000
T36.0 Penicillins	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
M85.65 Other cyst of bone (Pelvic region and thigh)	0.002	0.998	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.998	0.002
G45.4 Transient global amnesia	0.002	0.998	0.000
G46.2 Posterior cerebral artery syndrome	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
M19.96 Arthrosis, unspecified-Lower leg	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
M19.98 Arthrosis, unspecified (Other)	0.002	0.998	0.000
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.002	0.998	0.000
G46.8 Other vascular syndromes of brain in cerebrovascular diseases	0.002	0.998	0.000
G46.6 Pure sensory lacunar syndrome	0.002	0.998	0.000
G46.5 Pure motor lacunar syndrome	0.002	0.998	0.000
G46.1 Anterior cerebral artery syndrome	0.002	0.998	0.000
G46.0 Middle cerebral artery syndrome	0.002	0.998	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.998	0.002
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
E55.9 Vitamin D deficiency, unspecified	0.002	0.998	0.000
G41.1 Petit mal status epilepticus	0.002	0.998	0.000
R07.3 Other chest pain	0.002	0.998	0.000
C43 Malignant melanoma of skin	0.000	0.998	0.002
M54.3 Sciatica	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
G45 Transient cerebral ischaemic attacks and related syndromes	0.002	0.998	0.000
G41.8 Other status epilepticus	0.002	0.998	0.000
H35.8 Other specified retinal disorders	0.000	0.998	0.002
I44.5 Left posterior fascicular block	0.002	0.998	0.000
I44.2 Atrioventricular block, complete	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T78.3 Angioneurotic oedema	0.000	0.998	0.002
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
K74 Fibrosis and cirrhosis of liver	0.002	0.998	0.000
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.002	0.998	0.000
M54.30 Sciatica (Multiple sites in spine)	0.002	0.998	0.000
M81.20 Osteoporosis of disuse (Multiple sites)	0.001	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.000	0.998	0.002
M19.9 Arthrosis, unspecified	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
C43.9 Malignant melanoma of skin, unspecified	0.000	0.998	0.002
C49.5 Connective and soft tissue of pelvis	0.000	0.998	0.002
H90.2 Conductive hearing loss, unspecified	0.000	0.998	0.002
M85.6 Other cyst of bone	0.002	0.998	0.000
R19.5 Other fecal abnormalities	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.001
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.002	0.998	0.000
G45.1 Carotid artery syndrome (hemispheric)	0.002	0.998	0.000
H35.7 Separation of retinal layers	0.000	0.998	0.002
E24 Cushing's syndrome	0.002	0.998	0.000
J43 Emphysema	0.002	0.998	0.000
M19.92 Arthrosis, unspecified (Upper arm)	0.002	0.998	0.000
G41.2 Complex partial status epilepticus	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.001
M85.67 Other cyst of bone (Ankle and foot)	0.002	0.998	0.000
I44.0 Atrioventricular block, first degree	0.002	0.998	0.000
E16.2 Hypoglycaemia, unspecified	0.000	0.998	0.002
G45.0 Vertebro-basilar artery syndrome	0.002	0.998	0.000
G46.3 Brain stem stroke syndrome	0.001	0.998	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.002	0.998	0.000
M19.18 Post-traumatic arthrosis of other joints (Other)	0.002	0.998	0.000
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.002	0.998	0.000
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.002	0.998	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.000	0.998	0.002
I44.4 Left anterior fascicular block	0.002	0.998	0.000
K74.3 Primary biliary cirrhosis	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.000	0.998	0.002
E20-E35 Disorders of other endocrine glands	0.002	0.998	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.002	0.998	0.000
E24.0 Pituitary-dependent Cushing's disease	0.002	0.998	0.000
F43.1 Posttraumatic stress disorder	0.000	0.998	0.002
J43.8 Other emphysema	0.002	0.998	0.000
K70.0 Alcoholic fatty liver	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.002	0.998	0.000
K74.1 Hepatic sclerosis	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.001
Z63.4 Disappearance and death of family member	0.000	0.998	0.002
K73 Chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.001
W07.0 Home	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
C43.0 Malignant melanoma of lip	0.000	0.998	0.002
C49.4 Connective and soft tissue of abdomen	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations